<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To determine if levels of serum <z:chebi fb="1" ids="23965">estradiol</z:chebi> and <z:chebi fb="51" ids="17347">testosterone</z:chebi> can predict <z:hpo ids='HP_0001297'>stroke</z:hpo> in a population-based sample of elderly men </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Serum <z:chebi fb="0" ids="16469">17beta estradiol</z:chebi> and <z:chebi fb="51" ids="17347">testosterone</z:chebi> were measured in 2,197 men aged 71 to 93 years who participated in the Honolulu-Asia Aging Study from 1991 to 1993 </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> were free of prevalent <z:hpo ids='HP_0001297'>stroke</z:hpo>, <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e>, and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Participants were followed to the end of 1998 for thromboembolic and hemorrhagic events </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: During the course of follow-up, 124 men developed a <z:hpo ids='HP_0001297'>stroke</z:hpo> (9.1/1,000 person-years) </plain></SENT>
<SENT sid="5" pm="."><plain>After age adjustment, men in the top quintile of serum <z:chebi fb="1" ids="23965">estradiol</z:chebi> (&gt; or =125 pmol/L [34.1 pg/mL]) experienced a twofold excess risk of <z:hpo ids='HP_0001297'>stroke</z:hpo> vs men whose <z:chebi fb="1" ids="23965">estradiol</z:chebi> levels were lower (14.8 vs 7.3/1,000 person-years, p &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>Among the lower quintiles, there were little differences in the risk of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Findings were also significant and comparable for bioavailable <z:chebi fb="1" ids="23965">estradiol</z:chebi> and for thromboembolic and hemorrhagic events </plain></SENT>
<SENT sid="8" pm="."><plain>After additional adjustment for <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e>, cholesterol concentrations, <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo>, and other characteristics, men in the top quintile of serum <z:chebi fb="1" ids="23965">estradiol</z:chebi> continued to have a higher risk of <z:hpo ids='HP_0001297'>stroke</z:hpo> vs those whose <z:chebi fb="1" ids="23965">estradiol</z:chebi> levels were lower (relative hazards = 2.2; 95% CI = 1.5 to 3.4, p &lt; 0.001) </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="51" ids="17347">Testosterone</z:chebi> was not related to the risk of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: High levels of serum <z:chebi fb="1" ids="23965">estradiol</z:chebi> may be associated with an elevated risk of <z:hpo ids='HP_0001297'>stroke</z:hpo> in elderly men </plain></SENT>
</text></document>